October 2, 2023
Court sides with patient groups; copay accumulators now limited to branded drugs with generic equivalents.
August 29, 2023
HHS Names First Ten Drugs for Medicare Negotiations
August 22, 2023
The Network recently sent a support letter to congressional members on mitigating payment cuts to radiation oncology
August 21, 2023
Dr. Ralph Heaven of Texas Oncology Abilene publishes op-ed in Dallas Morning News on need for site neutral payments in Cancer Care.
July 19, 2023
On July 13, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule for the 2024 Medicare Physician Fee Schedule (PFS) and Quality Payment Program (QPP).
July 6, 2023
The US Oncology Network Applauds Reintroduction of the Medicare Patient Access to Cancer Treatment Act
The bill, introduced by Reps. Jodey Arrington (TX-19), Debbie Lesko (AZ-08), and Michael Burgess, M.D. (TX-26), would establish a more equitable reimbursement structure for cancer care delivered in the community setting.
May 19, 2023
The US Oncology Network Applauds Texas Lawmakers for Passing Legislation to Prohibit White Bagging Mandates
TX HB 1647 now goes to the Governor’s Desk for signature. WOODLANDS, Texas, May 17, 2023 —The US Oncology Network today commends Texas lawmakers for passing HB 1647 to prohibit pharmacy benefit managers (PBM) or insurers from requiring patients with life-threatening conditions to receive their clinician-administered drugs from a PBM mail-order specialty pharmacy. Prior to…
April 7, 2023
CMS issued the Medicare Advantage and Part D Final Rule for Contract Year 2024.
March 15, 2023
HHS Releases Initial Guidance for Medicare Drug Price Negotiation Program for Price Applicability Year 2026
The Negotiation program was created by the Inflation Reduction Act and authorizes CMS to negotiate Maximum Fair Prices for certain high expenditure, single source drugs and biological products.
March 7, 2023
On March 7, the White House released a fact sheet previewing proposals in the President’s forthcoming FY2024 budget aimed at extending the solvency of the Medicare program.